Maraviroc (UK-427857)是一种CCR5拮抗剂,作用于MIP-1α,MIP-1β和RANTES,无细胞试验中IC50分别为3.3 nM,7.2 nM和5.2 nM。Maraviroc可应用于治疗HIV感染。 Maraviroc has been used as a C-C chemokine receptor type 5 (CCR5-specific) inhibitor in murine monocyte/macrophage cell line J774A.1, porcine uterine luminal epithelial cells and human lung CD4+ T cells.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Maraviroc
Dangerous GoodsCAS number:376348-65-1 molecular formula:C29H41F2N5O
overview
compound introduction
Specs
| Chinese alias | 4,4-二氟-N-(1S)-3-(3-外)-3-3-甲基-5-(1-甲基乙基)-4H-1,2,4-三唑-4-基-8-氮杂双环 | 3.2.1 辛-8-基-1-苯基丙基 环己甲酰胺 | 马拉韦罗 | 马拉维若 | ||
| English alias | UK-427857 | ||
| CAS number | 376348-65-1 | molecular formula | C29H41F2N5O |
| molecular weight | 513.67 g/mol | Exact mass | - |
| PSA | 63.100 Ų | logp | 5.1 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08
Signal word:
Warning
Hazard Statement:
H373: 通过长时间或反复暴露对器官造成损害 H412: 对水生生物有害并具有长期持续影响
Statement of Preventive Measures:
P273: 避免释放到环境中。 P501: 将内容物/容器处理到。。。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P319: 如果你感到不适,请寻求医疗帮助。
WGK Germany:
1
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS




